Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA. 2016;316:1997 2007. 161. Stergiou GS, Asayama K, Thijs L, et al. Prognosis of white-coat and masked hypertension. Hypertension. 2014;63:675 82. 162. Sheridan S, Pignone M, Donahue K. Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force. Am J Prev Med. 2003;25:151 8. 163. Wolff T, Miller T. Evidence for the reaffirmation of the U.S. Preventive Services Task Force recommendation on screening for high blood pres- sure. Ann Intern Med. 2007;147:787 91. 164. Piper MA, Evans CV, Burda BU, et al. Screening for high blood pressure in adults: a systematic evidence review for the US Preventive Services Task Force. Evidence Synthesis No. 121. Rockville, MD: Agency for Healthcare Research and Quality; 2014. 165. Elwyn G, O Connor A, Stacey D, et al. Developing a quality criteria frame- work for patient decision aids: online international Delphi consensus pro- cess. BMJ Open. 2006;333:417. 166. Buhse S, M hlhauser I, Heller T, et al. Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabe- tes: a randomised controlled trial. BMJ Open. 2015;5:e009116. 167. Cooper LA, Roter DL, Carson KA, et al. A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients. J Gen Intern Med. 2011;26:1297 304. 168. Olomu A, Hart-Davidson W, Luo Z, et al. Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program. BMC Health Serv Res. 2016;16:334. 169. Parchman ML, Zeber JE, Palmer RF. Participatory decision making, pa- tient activation, medication adherence, and intermediate clinical out- comes in type 2 diabetes: a STARNet study. Ann Fam Med. 2010;8: 410 7. 170. 